Abstract:Background Cysteine protease cathepsins are important in extracellular matrix protein degradation, cell apoptosis, and angiogenesis. Mice lacking cathepsins are protected from tumor progression in several animal models, suggesting that the regulation of cathepsin activities controls the growth of various malignant tumors. Methods and Results We tested the role of cathepsins using a mouse model of multistage epithelial carcinogenesis, in which the human keratin-14 promoter/enhancer drove the expression of human papillomavirus type 16 (HPV16) early region E6/E7 transgenes. During the progression of premalignant dysplasia, we observed increased expression of cysteine protease cathepsin S, but concomitantly reduced expression of cathepsin endogenous inhibitor cystatin C in the skin tissue extract. Absence of cystatin C in these transgenic mice resulted in more progression of dysplasia to carcinoma in situ on the face, ear, chest, and tail. Chest and ear skin extract real time PCR and immunoblot analysis, mouse serum sample ELISA, tissue immunohistological analysis, and tissue extract-mediated in vitro elastinolysis and collagenolysis assays demonstrated that cystatin C deficiency significantly increased cathepsin expression and activity. In skin from both the chest and ear, we found that the absence of cystatin C reduced epithelial cell apoptosis but increased proliferation. From the same tissue preparations, we detected significantly higher levels of pro-angiogenic laminin 5-derived γ2 peptides and concurrently increased neovascularization in cystatin C-deficient mice, compared to those from wild-type control mice. Conclusion Enhanced cathepsin expression and activity in cystatin C-deficient mice contributed to the progression of dysplasia by altering premalignant tissue epithelial proliferation, apoptosis, and neovascularization.

Impaired Notch Signaling Promotes De Novo Squamous Cell Carcinoma Formation

Interplay Between Notch 1 and Notch 3 Promotes EMT and Tumor Initiation in Squamous Cell Carcinoma

Loss-Of-Function Mutations in Notch Receptors in Cutaneous and Lung Squamous Cell Carcinoma

The Notch1/Delta-like-4 axis is crucial for the initiation and progression of oral squamous cell carcinoma

Retraction Notice to “Notch-1 Induces Epithelial-mesenchymal Transition Consistent with Cancer Stem Cell Phenotype in Pancreatic Cancer Cells”

A Novel Mouse Model for Hedgehog Signaling-Mediated Carcinogenesis

Pten Loss in Lgr5+ Hair Follicle Stem Cells Promotes SCC Development

Notch signaling is significantly suppressed in basal cell carcinomas and activation induces basal cell carcinoma cell apoptosis.

Deletion of p53 and Hyper-Activation of PIK3CA in Keratin-15+ Stem Cells Lead to the Development of Spontaneous Squamous Cell Carcinoma

Cystatin C Deficiency Promotes Epidermal Dysplasia in K14-HPV16 Transgenic Mice.

Notch1 signaling contributes to stemness in head and neck squamous cell carcinoma

Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression

Loss of TGF-β Signaling and PTEN Promotes Head and Neck Squamous Cell Carcinoma Through Cellular Senescence Evasion and Cancer-Related Inflammation

The role of cornulin (CRNN) in the progression of cutaneous squamous cell carcinoma involving AKT activation in SCL-1

Mutant Nrf2E79Q enhances the promotion and progression of a subset of oncogenic Ras keratinocytes and skin tumors

Bi-compartmental communication contributes to the opposite proliferative behavior of Notch1-deficient hair follicle and epidermal keratinocytes

Epithelial stem cell mutations that promote Squamous cell carcinoma metastasis

Notch1 Loss of Heterozygosity Causes Vascular Tumors and Lethal Hemorrhage in Mice

Notch-Regulated Dendritic Cells Restrain Inflammation-Associated Colorectal Carcinogenesis

Pannexin 1 and Pannexin 3 differentially regulate the tumorigenic properties of cutaneous squamous cell carcinoma

Mutations in Long-Lived Epithelial Stem Cells and Their Clonal Progeny in Pre-Malignant Lesions and in Oral Squamous Cell Carcinoma.